The North American Creatinine Measurement Market is expected to reach US$ 269.75 million in 2027 from US$ 148.79 million in 2019. The market is estimated to grow with a CAGR of 7.8% from 2020-2027.
The growth of the creatinine measurement market is attributed to the increasing prevalence of chronic kidney disorders, growing geriatric population, and others. In recent years, the developments in the biotechnology sectors have accelerated due to the expansion of technological and engineering applications. The growth in biotechnology industry has enabled launches of various products based on bioengineering concepts. Thus, innovations have supported the introduction of various technically advanced systems and have enabled to improve healthcare facilities. Thus, technological factors are likely to foster the growth of the North America creatinine measurement market during the forecast period.
Various companies are focusing on the advancement of the Creatinine Measurement market. For instance, Abbott, Danaher, Siemens Healthineers, and Diazyme Laboratories, Inc. have done recent developments for products.
The Jaffe's Kinase method segment held the largest market share in the North American creatinine measurement market, which is attributed to the increasing adoption of this method due to extended range of advantages. Moreover, increasing prevalence of chronic kidney diseases coupled with growing awareness and availability of the product in considerable margins are projected to drive the growth of the segment during the forecast period.
The US registered as the fastest-growing region in the North American creatinine measurement market. The growth of the market in the US is attributed due to rising support from the government, increasing geriatric population, implementation of strategic marketing policies by major players, and increasing incidence of chronic kidney diseases.
American Society of Nephrology and US the Food and Drug Administration are the major primary and secondary sources for the creatinine measurement market included in the report.
Reasons to Buy
The growth of the creatinine measurement market is attributed to the increasing prevalence of chronic kidney disorders, growing geriatric population, and others. In recent years, the developments in the biotechnology sectors have accelerated due to the expansion of technological and engineering applications. The growth in biotechnology industry has enabled launches of various products based on bioengineering concepts. Thus, innovations have supported the introduction of various technically advanced systems and have enabled to improve healthcare facilities. Thus, technological factors are likely to foster the growth of the North America creatinine measurement market during the forecast period.
Various companies are focusing on the advancement of the Creatinine Measurement market. For instance, Abbott, Danaher, Siemens Healthineers, and Diazyme Laboratories, Inc. have done recent developments for products.
The Jaffe's Kinase method segment held the largest market share in the North American creatinine measurement market, which is attributed to the increasing adoption of this method due to extended range of advantages. Moreover, increasing prevalence of chronic kidney diseases coupled with growing awareness and availability of the product in considerable margins are projected to drive the growth of the segment during the forecast period.
The US registered as the fastest-growing region in the North American creatinine measurement market. The growth of the market in the US is attributed due to rising support from the government, increasing geriatric population, implementation of strategic marketing policies by major players, and increasing incidence of chronic kidney diseases.
American Society of Nephrology and US the Food and Drug Administration are the major primary and secondary sources for the creatinine measurement market included in the report.
Reasons to Buy
- Save and reduce time by carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America creatinine measurement market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America creatinine measurement market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering in developed and emerging markets.
- Scrutinize in-depth North American market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
3. Research Methodology
4. Creatinine Measurement - Market Landscape
5. Creatinine Measurement - Key Market Dynamics
6. Creatinine Measurement Market - Regional Analysis
7. Creatinine Measurement Market Analysis - By Product
8. Creatinine Measurement Market - By Type
9. Creatinine Measurement Market - By Sample Type
10. Creatinine Measurement Market Analysis - By End User
11. Creatinine Measurement Market - Regional Analysis
12. Creatinine Measurement Market- Industry Landscape
13. Creatinine Measurement Market - Key Company Profiles
14. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott
- Beijing Jiuqiang Biotechnology Co., Ltd.
- Beijing Leadman Biochemical Co., Ltd.
- Cayman Chemical
- Danaher
- Dialab GmbH
- Diazyme Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Fujifilm Wako Pure Chemical Corporation
- Randox Laboratories Ltd
- Shanghai Fosun Pharmaceutical Group Co., Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
